Clinical Trial Update: A Study to Evaluate VTX2735 in Patients With Cryopyrin-associated Periodic Syndrome [Phase 2]

View source ↗

Summary

This update reports the completion of a Phase 2 trial evaluating VTX2735 in patients with Cryopyrin-associated periodic syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cryopyrin-associated Periodic Syndrome

Drugs mentioned

• VTX2735

Snippet

Sponsor: Zomagen Biosciences Ltd. | Conditions: Cryopyrin Associated Periodic Syndrome | Phase 2 | Status: COMPLETED